MAPC Transplantation Confers a more Durable Benefit than AC133+ Cell Transplantation in Severe Hind Limb Ischemia
暂无分享，去创建一个
A. Luttun | E. Andreu | F. Prósper | B. Pelacho | Miriam Araña | G. Abizanda | I. Peñuelas | M. Ecay | Maialen Uriz | María Collantaes | M. Beerens | Giulia Coppiello | I. Prieto | Xabier L. Aranguren | M. Pérez‐Ilzarbe